10-K Filing

BNB PLUS CORP. CIK: 744452 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001410578-23-002615`
Period End Date	20230930
Filing Date	20231207
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	apdn-20230930x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 43 Cash Flow Statement 51 Stockholders Equity 19

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$330.85K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.15M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.22M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $75,000 and $330,853 at September 30, 2023 and 2022, respectively	`AccountsReceivableNetCurrent`	$255.50K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $75,000 and $330,853 at September 30, 2023 and 2022, respectively	`AccountsReceivableNetCurrent`	$3.07M	USD	Point-in-time
Inventories	`InventoryNet`	$602.24K	USD	Point-in-time
Inventories	`InventoryNet`	$330.03K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.06M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$389.24K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.13M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$19.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$838.27K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.91M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.22M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.66M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$1.24M	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$99.00K	USD	Point-in-time
Total assets	`Assets`	$13.65M	USD	Point-in-time
Total assets	`Assets`	$22.27M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.27M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.62M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$498.60K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$563.56K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$76.44K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.19M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$739.16K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$5.14M	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$4.29M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.78M	USD	Point-in-time
Commitments and contingencies (Note J)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note J)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30 2023 and 2022, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30 2023 and 2022, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2023 and 2022, 13,658,520 and 12,908,520 shares issued and outstanding as of September 30, 2023 and 2022, respectively	`CommonStockValue`	$13.66K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2023 and 2022, 13,658,520 and 12,908,520 shares issued and outstanding as of September 30, 2023 and 2022, respectively	`CommonStockValue`	$12.91K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$307.38M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$305.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.45M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-292.50M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$12.91M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$4.95M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-2.89K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-78.75K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$13.65M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$22.27M	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$13.37M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$18.17M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$13.12M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$7.83M	USD	Annual
Gross profit	`GrossProfit`	$5.05M	USD	Annual
Gross profit	`GrossProfit`	$5.53M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.75M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.10M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.74M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.93M	USD	Annual
Total operating expenses	`OperatingExpenses`	$19.02M	USD	Annual
Total operating expenses	`OperatingExpenses`	$16.49M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-13.97M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-10.95M	USD	Annual
Interest income	`InterestIncomeExpenseNet`	$7.20K	USD	Annual
Interest income	`InterestIncomeExpenseNet`	$75.33K	USD	Annual
Transaction cost allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-1.67M	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-18.00M	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-854.40K	USD	Annual
Loss on issuance of warrants	`LossOnIssuanceOfWarrants`	$10.59M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-47.30K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$642.00	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.02M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.27M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`ProfitLoss`	$-10.02M	USD	Annual
NET LOSS	`ProfitLoss`	$-8.27M	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.17K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-75.86K	USD	Annual
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-8.27M	USD	Annual
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-9.95M	USD	Annual
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$110.11K	USD	Annual
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.95M	USD	Annual
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.38M	USD	Annual
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.76	USD	Annual
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.93	USD	Annual
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.93	USD	Annual
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.76	USD	Annual
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.97M	shares	Annual
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.08M	shares	Annual
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.08M	shares	Annual
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.97M	shares	Annual

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-10.02M	USD	Annual
Net loss	`ProfitLoss`	$-8.27M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.36M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.29M	USD	Annual
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$6.08K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-18.00M	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-854.40K	USD	Annual
Transaction costs allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-1.67M	USD	Annual
Loss on issuance of warrants	`LossOnIssuanceOfWarrants`	$10.59M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.03M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.52M	USD	Annual
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$-239.04K	USD	Annual
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$269.45K	USD	Annual
Write-off of property and equipment	`WriteOffOfPropertyAndEquipment`	$62.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.05M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$532.96K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-767.69K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-272.22K	USD	Annual
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-767.81K	USD	Annual
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$493.22K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.35M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$930.50K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$282.56K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-293.12K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.22M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.98M	USD	Annual
Cash paid for Spindle asset purchase	`PaymentsToAcquireIntangibleAssets`	$1.06M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$45.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$489.55K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$78.45K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-489.55K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.10M	USD	Annual
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$3.70M	USD	Annual
Net proceeds from issuance of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$14.43M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.13M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.66M	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.31M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$110.11K	USD	Annual
Leased assets obtained in exchange for new operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55M	USD	Annual
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$25.94M	USD	Annual
Fair value of warrants exercised	`FairValueOfWarrantsExercised`	$2.80M	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssued1`	$952.50K	USD	Annual
Deferred tax liability for Spindle Acquisition	`LiabilitiesAssumed1`	$684.12K	USD	Annual
Issuance of stock options for payment of accrued bonus	`IssuanceOfStockOptionsIssuedForPaymentOfAccruedBonus`	$300.00K	USD	Annual

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$3.70M	USD	Annual
Derecognition of warrant liability	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.80M	USD	Annual
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.03M	USD	Annual
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.52M	USD	Annual
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-744.43K	USD	Annual
Options issued in settlement of accrued bonus	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$300.00K	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$952.50K	USD	Annual
Net income (loss)	`ProfitLoss`	$-10.02M	USD	Annual
Net income (loss)	`ProfitLoss`	$-8.27M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.